Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.
Abnormalities of chromosome 7q are common in myeloid malignancies, but no specific target genes have yet been identified. Here, we describe the finding of homozygous EZH2 mutations in 9 of 12 individuals with 7q acquired uniparental disomy. Screening of a total of 614 individuals with myeloid disord...
Auteurs principaux: | Ernst, T, Chase, A, Score, J, Hidalgo-Curtis, C, Bryant, C, Jones, A, Waghorn, K, Zoi, K, Ross, F, Reiter, A, Hochhaus, A, Drexler, H, Duncombe, A, Cervantes, F, Oscier, D, Boultwood, J, Grand, F, Cross, N |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2010
|
Documents similaires
-
Inactivating mutations of the histone methyltransferase EZH2 in myeloid disorders
par: Ernst, T, et autres
Publié: (2010) -
INACTIVATING MUTATIONS OF THE HISTONE METHYLTRANSFERASE EZH2 ARE ASSOCIATED WITH CHROMOSOME 7 ABNORMALITIES IN MYELOID DISORDERS
par: Ernst, T, et autres
Publié: (2010) -
Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms
par: Thomas Ernst, et autres
Publié: (2010-09-01) -
EZH2 in Myeloid Malignancies
par: Jenny Rinke, et autres
Publié: (2020-07-01) -
Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
par: Su, I-hsin, et autres
Publié: (2013)